Search

Your search keyword '"Seth, Amlesh"' showing total 8 results
Start Over Author "Seth, Amlesh" Journal indian journal of cancer
8 results on '"Seth, Amlesh"'

1. Survival analysis and predictors of long-term outcomes following radical nephrectomy with inferior vena cava (IVC) thrombectomy in renal cell carcinoma

Author

Garg, Harshit, Nayak, Brusabhanu, Kumar, Ashish, Singh, Prabhjot, Nayyar, Rishi, Kaul, Aashir, and Seth, Amlesh

Subjects
Medical research, Medicine, Experimental, Blood clot -- Care and treatment -- Patient outcomes, Thrombosis -- Care and treatment -- Patient outcomes, Carcinoma, Renal cell -- Care and treatment -- Patient outcomes, Health
Abstract

Byline: Harshit. Garg, Brusabhanu. Nayak, Ashish. Kumar, Prabhjot. Singh, Rishi. Nayyar, Aashir. Kaul, Amlesh. Seth Background: Renal cell carcinoma (RCC) presents with inferior vena cava (IVC) thrombus in 10%-30% cases [...]

Published
2023

2. Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario

Author

Narain, Tushar, Gautam, Gagan, Seth, Amlesh, Panwar, Vikas, Rawal, Sudhir, Dhar, Puneet, Talwar, Harkirat, Singh, Amitabh, Jaipuria, Jiten, and Mittal, Ankur

Subjects
Health care industry -- Health aspects, Virus diseases -- Health aspects, Sunitinib -- Health aspects, COVID-19 -- Health aspects, Health care industry, Health
Abstract

Byline: Tushar. Narain, Gagan. Gautam, Amlesh. Seth, Vikas. Panwar, Sudhir. Rawal, Puneet. Dhar, Harkirat. Talwar, Amitabh. Singh, Jiten. Jaipuria, Ankur. Mittal The Corona Virus Disease-2019 (COVID-19), one of the most [...]

Published
2020

4. A comparative study of the effects of medical versus surgical androgen deprivation therapy on health-related quality of life in patients with metastatic carcinoma prostate

Author

Singh, Prabhjot, Agrawal, Tapan, Yadav, Siddharth, Nayak, Brusabhanu, Seth, Amlesh, and Dogra, Prem

Subjects
Androgen suppression therapy -- Health aspects, Prostate cancer -- Diagnosis, Quality of life -- Analysis, Health
Abstract

Byline: Prabhjot. Singh, Tapan. Agrawal, Siddharth. Yadav, Brusabhanu. Nayak, Amlesh. Seth, Prem. DograINTRODUCTION: Androgen deprivation therapy (ADT) is known to adversely affect the quality of life (QoL). One may choose [...]

Published
2018

5. Massive pleural effusion without bony involvement: an unusual presentation of advanced carcinoma prostate

Author

Ansari, M.S., Nabi, Gholam, and Seth, Amlesh

Subjects
Pleural effusions -- Diagnosis, Pleural effusions -- Care and treatment, Prostate cancer -- Complications
Abstract

Code Number: cn02008 ABSTRACT As noted under the natural history, the bone of axial skeleton and the ileopelvic lymphnodes specially the obturator groups are the commonest sites of metastasis spread [...]

Published
2002

6. Pattern of metastases in renal cell carcinoma: A single institution study

Author

Gupta, Narmada, Wadhwa, Pankaj, Hemal, Ashok, Dogra, Prem, Seth, Amlesh, Aron, Monish, Kumar, Rajeev, and Sivaramakrishna, B.

Subjects
Carcinoma, Renal cell -- Care and treatment
Abstract

Byline: B. Sivaramakrishna, Narmada. Gupta, Pankaj. Wadhwa, Ashok. Hemal, Prem. Dogra, Amlesh. Seth, Monish. Aron, Rajeev. Kumar Background: Increasing numbers of patients with renal cell carcinoma (RCC) are incidentally detected [...]

Published
2005

8. Survival analysis and predictors of long-term outcomes following radical nephrectomy with inferior vena cava (IVC) thrombectomy in renal cell carcinoma.

Author

Garg H, Nayak B, Kumar A, Singh P, Nayyar R, Kaul A, and Seth A

Abstract

Background: Renal cell carcinoma (RCC) presents with inferior vena cava (IVC) thrombus in 10%-30% cases and surgical management forms the mainstay of the treatment. The objective of this study is to assess the outcomes of the patients undergoing radical nephrectomy with IVC thrombectomy., Methods: A retrospective analysis of patients undergoing open radical nephrectomy with IVC thrombectomy between 2006 till 2018 was done., Results: A total of 56 patients were included. The mean (±standard deviation) age was 57.1 (±12.2) years. The number of patients with levels I, II, III, and IV thrombus were 4, 29,10, and 13, respectively. The mean blood loss was 1851.8 mL, and the mean operative time was 303.3 minutes. Overall, the complication rate was 51.7%, while the perioperative mortality rate was 8.9%. The mean duration of hospital stay was 10.6 ± 6.4 days. The majority of the patients had clear cell carcinoma (87.5%). There was a significant association between grade and stage of thrombus (P = 0.011). Using Kaplan-Meier survival analysis, the median overall survival (OS) was 75 (95% confidence interval [CI] = 43.5-106.5) months, and the median recurrence-free survival (RFS) was 48 (95% CI = 33.1-62.3) months. Age (P = 0.03), presence of systemic symptoms (P = 0.01), radiological size (P = 0.04), histopathological grade (P = 0.01), level of thrombus (P = 0.04), and invasion of thrombus into IVC wall (P = 0.01) were found to be significant predictors of OS., Conclusion: The management of RCC with IVC thrombus poses a major surgical challenge. Experience of a center along with high-volume and multidisciplinary facility particularly cardiothoracic facility provides better perioperative outcome. Though surgically challenging, it offers good overall-survival and recurrence-free survival., Competing Interests: None

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results